Evidence packet 7 · filing-time record

EQUIFAX INC (EFX)

A self-contained audit view of the featured disclosure change. Market outcomes are shown only in the separately labeled ex-post panel.

Selection rule: Corpus-bounded genuinely new annual disclosure. Case selection used evidence diversity and clarity—not future outcomes.
Current 10-K2022-02-24Open SEC filing
Prior 10-K2021-02-25Open SEC filing
ClassificationLitigation or regulatory escalationnegative · high · confidence 0.941
Noveltygenuinely new in the 10-KCorpus-bounded prior-source check

Prior filing excerpt

The remaining $346.7 million to be paid to the Consumer Restitution Fund will be made after a final adjudication affirming the U.S. Consumer MDL Litigation Settlement or dismissal of the pending appeals. Although we expect this payment and the remaining settlement payments to be made in 2021, we can give no assurance that these payments will occur in 2021 due to pending approvals or appeals. As a result of the possible payments that could be made in 2021 related to the losses associated with certain legal proceedings and government investigations related to the 2017 cybersecurity incident and other requirements, funds generated by operating activities may not be sufficient to fund working capital and other cash requirements, including for acquisitions and share repurchases, throughout 2021. Our plan is to finance the payments with existing cash balances and borrowing capacity, as necessa

Current filing excerpt

To the extent we are unable to comply or we are viewed as not being in compliance with these business practice commitments or other requirements of a relevant order, we could face an enforcement action or contempt proceeding that could potentially result in fines, penalties and new business practice commitments, which, depending on the amount and type, could have a material adverse effect on our financial condition. In addition, we may be required to deposit additional amounts in the consumer settlement fund under certain circumstances if the fund is insufficient to cover claims and certain expenses. While we do not believe that we will be required to deposit additional amounts into the consumer settlement fund based on our claims experience to date, we could be obligated to fund up to an additional $125 million if our claims experience changes and the consumer fund is exhausted.

Added language

To the extent we are unable comply or we are viewed as not being in compliance with these business practice commitments or other requirements of a relevant order, we could face an enforcement action or contempt proceeding that could potentially result in fines, penalties and new business practice commitments, which, depending on the amount and type, could have a material adverse effect on our financial condition. In addition, we may required deposit additional amounts in consumer settlement fund under certain circumstances if the fund is insufficient to cover claims and certain expenses. While we do not believe that we required to deposit add

Removed language

The remaining $346.7 million paid Consumer Restitution Fund made after a final adjudication affirming U.S. Consumer MDL Litigation Settlement or dismissal of the pending appeals. Although expect this payment remaining settlement payments to be made in 2021, we can give no assurance that these payments will occur in 2021 due to pending approvals or appeals. As a result of the possible payments that could be made in 2021 related to the losses associated with certain legal proceedings and government investigations related to the 2017 cybersecurity incident and other requirements, funds generated by operating activities may not be sufficient to w

Why an analyst may care

Escalating legal or regulatory exposure can affect cash flows, operations, and management attention.

Earlier point-in-time evidence

Document provenance

Current primary-document SHA-256
dce64b7df4929cab0a9217c04260cf10d714fe878df43c3dbce5fc963c49f9d1
Prior primary-document SHA-256
666b16ae9f1f78659d5c3d397eabcbadde547921990c6f251ec5fefaec915943
Method
deterministic-evidence-rule-v1

Limitation: This is deterministic, corpus-bounded research triage. Novelty is limited to searched frozen sources; the category is not a causal claim or investment recommendation.